High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma

医学 肝细胞癌 放射外科 多元分析 肝癌 剂量分馏 放射治疗 核医学 队列 内科学 放射科 肿瘤科
作者
Won Sik Jang,Misook Kim,Sun Sik Bae,Chul Koo Cho,Hyung Joon Yoo,Young Joon Seo,Jin-Kyu Kang,So Young Kim,Dong Ho Lee,Chul Han,Jin-Soo Kim,Su Bum Park,Sang Hoon Kim,Eung-Ho Cho,Young Ho Kim
出处
期刊:Radiation Oncology [BioMed Central]
卷期号:8 (1) 被引量:149
标识
DOI:10.1186/1748-717x-8-250
摘要

Abstract Background Recent studies using stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) have reported high tumor response and local control. However, the optimal SBRT dose remains unknown, and it is still not clear whether a dose response relationship for local control (LC) and overall survival (OS) exist or not. We performed this study to determine whether a dose response relationship for LC and OS is observed in SBRT for inoperable HCC. Methods Between 2003 and 2011, 108 patients with HCC were treated with SBRT. All patients were unsuitable for surgery or local ablation and had incomplete response to transarterial chemoembolization. Eighty-two patients with a longest tumor diameter (LD) less than or equal to 7.0 cm who were treated with 3-fraction SBRT and were analyzed. This cohort comprised 74 Child-Turcotte-Pugh (CTP) class A patients and 8 CTP class B7 patients. The median LD was 3.0 cm (range, 1.0–7.0 cm), and the median dose was 51 Gy (range, 33–60 Gy). Results LC and OS rates at 2 years after SBRT were 87% and 63%, respectively, with a median follow-up duration of 30 months for all patients. The 2-year LC/OS rates for patients treated with doses of > 54, 45–54, and < 45 Gy were 100/71, 78/64, and 64%/30%, respectively (p = .009/p < .001). Multivariate analysis revealed that the SBRT dose (p = .005) and Barcelona Clinic Liver Cancer stage (p = .015) were significant prognostic factors for OS. Correlation analysis revealed a positive linear relationship between the SBRT dose and LC (p = .006, R = .899)/OS (p = .002, R = .940) at 2 years. Based on the tumor-control probability model, a dose of 54.8 Gy provides 2-year LC with a 90% probability. Five patients experienced grade 3 or higher gastrointestinal toxicity, and 6 had deteriorating of CTP score by greater than or equal to 2 within 3 months of SBRT. Conclusions This study demonstrated a dose response relationship for LC and OS with SBRT for HCC. Higher LC rates resulting from an increased dose may translate into survival benefits for patients with HCC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
猪突猛进发布了新的文献求助10
1秒前
1秒前
1秒前
null的应助被cwc采纳,获得10
1秒前
2秒前
CipherSage的应助被cwc采纳,获得10
2秒前
乐乐的应助被LXF采纳,获得10
2秒前
英俊的铭的应助被海洋采纳,获得10
2秒前
pluto的应助被malele采纳,获得10
2秒前
小鱼爱吃肉的应助被KGP采纳,获得10
2秒前
orixero的应助被malele采纳,获得10
2秒前
勤劳水云完成签到 ,获得积分20
2秒前
3秒前
望舒发布了新的文献求助10
3秒前
huhuodan发布了新的文献求助50
4秒前
umw完成签到,获得积分10
5秒前
5秒前
5秒前
wmeng给wmeng的求助进行了留言
6秒前
molihuakai的应助被GG采纳,获得10
6秒前
情怀的应助被古月方源采纳,获得10
6秒前
苏沐完成签到,获得积分10
7秒前
7秒前
7秒前
Epoch发布了新的文献求助10
7秒前
7秒前
孟富泉完成签到,获得积分10
8秒前
8秒前
海拾月完成签到,获得积分10
8秒前
核桃的应助被整齐的从丹采纳,获得30
8秒前
yezi完成签到,获得积分10
8秒前
9秒前
9秒前
9秒前
9秒前
9秒前
地上科研888完成签到,获得积分20
10秒前
10秒前
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8155073
求助须知:如何正确求助?哪些是违规求助? 9551529
关于积分的说明 21705228
捐赠科研通 7744266
什么是DOI,文献DOI怎么找? 3425957
关于科研通互助平台的介绍 2551109
邀请新用户注册赠送积分活动 2469734